CN Stock MarketDetailed Quotes
301075 Tibet Duo Rui Pharmaceutical
- 21.52
- +1.77+8.96%
Market Closed Oct 15 15:00 CST
1.72BMarket Cap1434.67P/E (TTM)
23.70High19.48Low70.10KlotVolume19.48Open19.75Pre Close154.35MTurnover8.76%Turnover Ratio91.19P/E (Static)80.00MShares30.8852wk High2.33P/B1.72BFloat Cap12.4852wk Low23.70Limit Up80.00MShs Float53.80Historical High15.80Limit Down21.37%Amplitude12.48Historical Low0.13Dividend TTM22.02Avg Price36.44KlotAsk0.58%Div YieldTTM100Lot Size30.28KlotBid
Tibet Duo Rui Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -29.17%138.94M | -24.67%78.61M | -15.41%389.45M | -9.17%314.45M | -10.23%196.17M | -7.24%104.36M | -22.60%460.42M | -21.93%346.21M | -24.69%218.52M | -17.73%112.5M |
| Cash received relating to other operating activities | -64.72%5.47M | -72.89%3.43M | -39.52%18.53M | 15.95%25.99M | -8.18%15.5M | 36.40%12.66M | 88.07%30.64M | 189.80%22.42M | 271.47%16.88M | 112.33%9.28M |
| Cash inflows from operating activities | -31.77%144.41M | -29.89%82.04M | -16.92%407.98M | -7.65%340.45M | -10.08%211.67M | -3.91%117.02M | -19.69%491.06M | -18.36%368.63M | -20.21%235.4M | -13.70%121.78M |
| Goods services cash paid | 43.13%85.78M | 43.76%38.95M | 7.08%120.8M | 3.94%82.83M | 71.44%59.93M | -22.70%27.1M | 156.39%112.81M | 197.48%79.69M | 90.30%34.96M | 227.51%35.05M |
| Staff behalf paid | 15.41%24.89M | 11.09%13.87M | 1.52%42.89M | 1.26%32.01M | -1.91%21.56M | 10.43%12.48M | 5.77%42.25M | -1.91%31.61M | -5.00%21.98M | -15.02%11.3M |
| All taxes paid | -39.29%12.17M | -29.59%6.55M | -2.60%38.3M | -8.47%30.14M | -2.98%20.05M | 124.70%9.3M | -41.70%39.32M | -39.95%32.93M | -41.26%20.67M | -74.02%4.14M |
| Cash paid relating to other operating activities | -45.29%59.1M | -29.47%35.59M | -34.50%193.58M | -31.90%171.3M | -29.81%108.03M | -41.94%50.46M | -28.25%295.56M | -15.62%251.55M | -9.87%153.91M | 9.73%86.91M |
| Cash outflows from operating activities | -13.19%181.94M | -4.41%94.96M | -19.26%395.57M | -20.09%316.28M | -9.48%209.58M | -27.70%99.34M | -13.03%489.94M | -3.93%395.79M | -6.44%231.52M | 15.33%137.41M |
| Net cash flows from operating activities | -1,895.79%-37.53M | -173.09%-12.92M | 1,001.79%12.41M | 188.98%24.17M | -46.05%2.09M | 213.05%17.67M | -97.66%1.13M | -168.67%-27.16M | -91.85%3.87M | -171.16%-15.63M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --401.01M | 38.80%229.01M | 92.52%541M | --286.66M | ---- | --165M | 181.00%281M | ---- | ---- | ---- |
| Cash received from returns on investments | 218.54%1.84M | 38.18%798.9K | 102.68%2.81M | 813.33%2.28M | --578.15K | --578.15K | 665.12%1.39M | --249.47K | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | 7,058.10%572.65K | 10.97%563.75K | ---- | ---- | --8K | --508K | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --536.9K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | -68.46%46.31M | 6,115.48%62.17M | 11.36%159.79M | ---- | -6.47%146.84M | --1M | --143.49M | --229M | --157M | ---- |
| Cash inflows from investing activities | 204.68%449.16M | 75.29%291.98M | 65.47%704.71M | 26.00%289.5M | -6.10%147.42M | --166.57M | 325.11%425.88M | --229.76M | --157M | ---- |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -22.76%11.43M | 418.81%6.91M | -27.61%23.69M | -27.53%17.75M | -34.27%14.8M | -91.40%1.33M | 512.19%32.73M | 513.24%24.49M | 704.50%22.52M | 731.52%15.5M |
| Cash paid to acquire investments | 32.54%192.19M | 115.82%336.7M | 25.82%586.31M | 602.99%358.53M | 806.25%145M | 875.06%156.01M | 366.00%466M | --51M | --16M | --16M |
| Net cash paid to acquire subsidiaries and other business units | ---- | --11.33M | --35.09M | --2.69M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid relating to other investing activities | --297.37M | --159.84M | -1.54%128M | -99.64%1.11M | ---- | ---- | 18.18%130M | --311M | --224M | ---- |
| Cash outflows from investing activities | 213.51%500.99M | 227.17%514.78M | 22.96%773.09M | -1.66%380.08M | -39.13%159.8M | 399.50%157.34M | 191.96%628.73M | 9,577.74%386.49M | 9,279.75%262.52M | 1,589.87%31.5M |
| Net cash flows from investing activities | -318.58%-51.82M | -2,513.42%-222.8M | 66.29%-68.38M | 42.21%-90.57M | 88.27%-12.38M | 129.31%9.23M | -76.13%-202.84M | -3,824.60%-156.73M | -3,670.11%-105.52M | -1,589.87%-31.5M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --900K | -36.43%2.6M | ---- | ---- | ---- | -99.19%4.09M | -99.29%3.6M | --3.6M | --2.6M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | -36.43%2.6M | ---- | ---- | ---- | --4.09M | --3.6M | --3.6M | --2.6M |
| Cash from borrowing | -6.96%94.9M | 89.80%94.9M | 130.10%230.1M | 200.25%120.1M | 155.00%102M | --50M | 100.00%100M | 33.33%40M | 33.33%40M | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | --20M | --27.74M | --9.9M | ---- |
| Cash inflows from financing activities | -6.96%94.9M | 91.60%95.8M | 87.52%232.7M | 68.34%120.1M | 90.64%102M | 1,823.08%50M | -77.75%124.09M | -86.73%71.34M | 78.35%53.5M | -91.33%2.6M |
| Borrowing repayment | 45.00%58M | --128K | 680.00%156M | --50M | --40M | ---- | -69.23%20M | ---- | ---- | ---- |
| Dividend interest payment | 1,427.02%12.74M | 190.35%1.34M | -93.60%3.25M | -97.37%1.32M | -98.32%834.08K | --461.25K | 4,307.00%50.84M | 5,462.59%50.07M | 8,099.16%49.6M | ---- |
| Cash payments relating to other financing activities | --20.99M | --20M | 53.04%12.57M | ---- | ---- | ---- | -83.01%8.22M | 37.07%6.26M | 151.05%3.26M | --3M |
| Cash outflows from financing activities | 124.64%91.73M | 4,553.93%21.47M | 117.36%171.83M | -8.90%51.32M | -22.75%40.83M | -84.63%461.25K | -30.97%79.05M | 39.19%56.33M | 43.23%52.86M | -91.50%3M |
| Net cash flows from financing activities | -94.81%3.17M | 50.05%74.33M | 35.16%60.87M | 358.18%68.78M | 9,408.15%61.17M | 12,484.69%49.54M | -89.84%45.04M | -96.98%15.01M | 109.32%643.3K | 92.47%-400K |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -269.39%-86.18M | -311.12%-161.39M | 103.13%4.91M | 101.41%2.37M | 150.37%50.87M | 260.82%76.44M | -141.64%-156.68M | -131.69%-168.88M | -366.93%-101M | -421.31%-47.53M |
| Add:Begin period cash and cash equivalents | -22.73%329M | -22.41%329M | -32.59%324.09M | -11.80%424.05M | -11.44%425.76M | -11.80%424.05M | 360.10%480.77M | 360.10%480.77M | 360.10%480.77M | 360.10%480.77M |
| End period cash equivalent | -49.06%242.82M | -66.51%167.62M | 1.51%329M | 36.72%426.42M | 25.51%476.64M | 15.52%500.49M | -32.59%324.09M | -51.07%311.89M | 166.83%379.77M | 263.19%433.24M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data